Ryan J. Brisson

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

Tanguy Y. Seiwert, Corey C. Foster, Elizabeth A. Blair et al. · Annals of Oncology · 2018 · 220 citations · Full text

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer

Victoria Villaflor, J.M. Melotek, Theodore Karrison et al. · Annals of Oncology · 2016 · 95 citations

Advanced Head, Response-adapted Volume De-escalation, Neck Cancer +13

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Corey C. Foster, Marcus Couey, Sara Kochanny et al. · Cancer · 2021 · 75 citations · Full text

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

Corey C. Foster, J.M. Melotek, Ryan J. Brisson et al. · Oral Oncology · 2018 · 54 citations

Definitive Chemoradiation, Medicine, Oral Cavity +6

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer

Tanguy Y. Seiwert, J.M. Melotek, Elizabeth A. Blair et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 36 citations

Final Results, Neck Cancer, Randomized Phase 2 +10